Nevins T E, Gaston T, Basgen J M
Am J Pathol. 1984 Oct;117(1):30-6.
Aminonucleoside of puromycin (PAN) is known to cause altered glomerular permeability, resulting in a nephrotic syndrome in rats. The early sequence of this lesion was studied quantitatively, with the application of a new morphometric technique for determining epithelial foot process widths and a sensitive assay for quantifying urinary albumin excretion. Twenty-four hours following a single intraperitoneal injection of PAN, significant widening of foot processes was documented. Within 36 hours significant increases in urinary albumin excretion were observed. When control rats were examined, there was no clear correlation between epithelial foot process width and quantitative albumin excretion. However, in the PAN-treated animals, abnormal albuminuria only appeared in association with appreciable foot process expansion. These studies indicate that quantitative alterations occur in the rat glomerular capillary wall as early as 24 hours after PAN. Further studies of altered glomerular permeability may use these sensitive measures to more precisely define the temporal sequence and elucidate possible subgroups of experimental glomerular injury.
嘌呤霉素氨基核苷(PAN)已知会导致肾小球通透性改变,从而在大鼠中引发肾病综合征。运用一种用于确定上皮足突宽度的新形态计量学技术和一种用于量化尿白蛋白排泄的灵敏检测方法,对该病变的早期过程进行了定量研究。单次腹腔注射PAN后24小时,记录到足突明显增宽。在36小时内,观察到尿白蛋白排泄显著增加。检查对照大鼠时,上皮足突宽度与定量白蛋白排泄之间没有明显的相关性。然而,在接受PAN治疗的动物中,异常蛋白尿仅在足突明显扩张时出现。这些研究表明,早在PAN注射后24小时,大鼠肾小球毛细血管壁就发生了定量改变。对肾小球通透性改变的进一步研究可使用这些灵敏的指标,更精确地确定时间顺序,并阐明实验性肾小球损伤可能的亚组。